Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Clinical trial NCT00081159 · COMPLETED
Trial details
- NCT number
- NCT00081159
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2014-09-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.